Invention Grant
- Patent Title: Stabilized leukotriene B4 (LTB4) agent pharmaceutical formulation
- Patent Title (中): 稳定白三烯B4（LTB4）药剂制剂
-
Application No.: US11231359Application Date: 2005-09-20
-
Publication No.: US08664271B2Publication Date: 2014-03-04
- Inventor: Pierre Borgeat
- Applicant: Pierre Borgeat
- Applicant Address: SE Stockholm
- Assignee: LTB4 Sweden AB
- Current Assignee: LTB4 Sweden AB
- Current Assignee Address: SE Stockholm
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi; Matthew Pavao, J.D.
- Main IPC: A61K31/202
- IPC: A61K31/202
Abstract:
The present invention relates to a novel pharmaceutical formulation comprising an LTB4 agent at an alkaline pH effective to stabilize the LTB4 agent and provide a formulation with an increased shelf-life. The formulation of the present invention has an increased shelf-life of at least 24 months.
Public/Granted literature
- US20060063837A1 Stabilized leukotriene B4 (LTB4) agent pharmaceutical formulation Public/Granted day:2006-03-23
Information query
IPC分类:
